Marine Bio (MBII) Misses Q1 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil steady as investors focus on Hormuz flows after peace talks
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Marrone Bio Innovations, Inc. Reports 2016 First Quarter Results
May 12, 2016 4:10 PM EDTFirst Quarter Total Revenues Increased 30% to $2.7 million
First Quarter Product Shipments Increased 79% to $3.9 million
Achieved Seed-Treatment Deal, Zequanox Project Funded, Expanded Commercial Team and Progressed Toward Other Key Operational Objectives
DAVIS, Calif.--(BUSINESS WIRE)-- Marrone Bio Innovations, Inc. (the Company or we) (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the... More
